Like a seedling nurtured to become a sturdy tree, India's Production Linked Incentive (PLI) Scheme aims to transform the healthcare manufacturing landscape. With far-reaching objectives such as cultivating a self-reliant industry, fostering innovation, job creation, and export growth, it would be interesting to see whether the scheme turns out to be a game-changer for India's healthcare sector.
The Production Linked Incentive (PLI) Scheme is a strategic initiative by the Indian government to boost domestic manufacturing, enhance exports, and create employment opportunities.
The scheme is available pharmaceutical and medical for devices manufacturers in India. The domestically manufactured pharma products as well as medical devices should meet the prescribed criteria related to production, innovation, and domestic value addition. The incentives are based on incremental sales over the base year of FY 2019-20.
Inaugurated in 2021, with a financial outlay of ₹15,000 crores over six years, the PLI scheme for pharmaceutical manufacturers covers active pharmaceutical ingredients (APIs), formulations (finished dosage forms, such as tablets, capsules, and injectables), and biopharmaceuticals:
• Category 1: Encompassing biopharmaceuticals, complex generic drugs, patented drugs, cell-based or gene therapy drugs, orphan drugs, special empty capsules, and complex excipients.
• Category 2: Focused on bulk drugs, excluding those notified under the "PLI Scheme for Bulk Drugs.
• Category 3: Encompassing drugs not included in Category 1 and Category 2, such as repurposed drugs, auto-immune drugs, anti-cancer drugs, anti-diabetic drugs, antiinfective drugs, cardiovascular drugs, psychotropic drugs, anti-retroviral drugs, and in vitro diagnostic devices.
هذه القصة مأخوذة من طبعة July 2024 من Healthcare Radius.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة July 2024 من Healthcare Radius.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
A breakthrough in sleep apnea treatment arrives in India
According to ResMed 2024 Global Sleep Survey, a startling 46% of participants had a history of Obstructive Sleep Apnea.
REVOLUTIONIZING ANTENATAL CARE: THE TRANSFORMATIVE ROLE OF GENOMICS AND AI IN SHAPING PRENATAL HEALTH
No longer confined to routine checkups and ultrasounds, prenatal care now encompasses a sophisticated array of genetic analysis, offering expectant parents a deeper understanding of their developing child and enabling proactive management of potential health challenges.
CHECKPOINT INHIBITORS IN RARE CANCERS: EXPANDING TREATMENT HORIZONS
Immune checkpoint inhibitors are transforming oncology, offering new hope for patients with rare cancers. By unleashing the immune system against cancer cells, these therapies redefine treatment possibilities, improving survival and quality of life in hard-to-treat malignancies.
ADVANCEMENTS IN NEUROFEEDBACK THERAPY: IMPLICATIONS FOR TREATING NEURODIVERGENT STUDENTS IN ACADEMIC ENVIRONMENTS
With ongoing research and innovation, the future of neurofeedback therapy holds significant promise for transforming the educational experiences of neurodivergent youngsters.
Woman undergoes 3D laparoscopic surgery for gallbladder condition
The patient had come to MASSH with a large, 18mm stone lodged in the neck of her gallbladder, a location that posed a high risk of rupture.
Blinkit app adds emergency ambulance service, assures 10-minute arrival time
The company has launched its first fleet of five Basic Life Support (BLS) ambulances, making emergency medical transport accessible through its mobile app.
New FOGSI President unveils key initiatives for women's health in India
Dr. Sunita Tandulwadkar, a globally recognized infertility specialist, endoscopic surgeon, and gynecologist, was formally installed as the 63rd President of FOGSI.
Pune's first robotic-assisted hip replacement improves recovery and mobility for patient
The use of the real intelligence robotic system combined with the direct anterior approach has set a new standard in the field.
ZENZO ensures 15-minute response across 450+ cities
The ZENZO AMBULANCE NETWORK supports the ONE NATION, ONE NUMBER, ONE PRICING concept.
HOW CAR T-CELL THERAPY IS ADVANCING HEALTHCARE THROUGH PRECISION AND AI INTEGRATION
The combination of human expertise and artificial intelligence may well represent the future of personalized cancer care, offering hope to patients who previously had limited options.
